TickerFacts.

RenovoRx, Inc. (RNXT): Depreciation & Amortization

Annual figures by period end, from SEC filings.

$2.00M
Year ended 2025-12-31
2024-12-31: $02025-12-31: $2.00M$2.00M
2024-12-31 Depreciation & Amortization (USD) 2025-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2025-12-31$2.00Mn/a2026-03-30, From 2025-01-01
2024-12-31$0n/a2026-03-30, From 2024-01-01

Depreciation & Amortization at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedDepreciation & AmortizationChange YoY
RenovoRx, Inc. (RNXT)2025-12-31$2.00Mn/a
PetVivo Holdings, Inc. (PETV)2026-03-31$511.5K+192.9%
Catheter Precision, Inc. (VTAK)2025-12-31$2.12M+0.3%
EBR Systems, Inc. (NONE.)2025-12-31$403.0K-31.3%
Vycor Medical Inc (VYCO)2025-12-31$59.5K0.0%
Co-Diagnostics, Inc. (CODX)2025-12-31$1.11M-19.6%
Femasys Inc (FEMY)2025-12-31$342.0K+15.0%
QHSLab, Inc. (USAQ)2025-12-31$90.7K-38.1%
Tenon Medical, Inc. (TNON)2025-12-31$262.0K-35.8%

Compare RNXT, PETV, VTAK, NONE. side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗